Blood coming out of blood vessels is
known as bleeding. Bleeding may be internal or external depends upon
type of injury. Gel which are intended to stop the bleeding are known as
anti-bleeding gel. Antibleeding gel is a semi-clear gel that instantly
stops internal and external bleeding. The gel stops bleeding and speeds
along the process of healing. The gel works to stick blood platelets
together to active clotting factor, this then leads to beginning of
healing process. This gel is used on skin wounds, the anti-bleeding gel
works on surface bleeding as opposed to deep cuts or extremely severe
wounds. Antibleeding gel is nor used if the cut or wound is more severe
or in infected wound.'
Vetigel is the first antibleeding gel
invented by 17 year old student of New York university student Joe
Landolina, now e is CEO of biotech company Suneris (now known as
Cresilon, Inc.). He formed the gel made from algae based polymer (plant
polymers) that mimics the human extracellular matrix, or ECM, the
substance that forms a kind of scaffoldings in the body to holds cells
together and also trigger the clotting process if there is an injury.
The gel stops bleeding in 12 seconds and start healing process. Vetigel
is the hemostasis gel kit for animal use only, and trails are going for
human use, if the gel gains FDA approval for human use, it will be first
used by military persons, then to treat traumatic condition, then in
operation rooms and finally for individuals home.
The another product LeGoo gel used to
stop or control temporary bleeding in surgery.to join the blood vessels
during surgery, it is necessary to temporary stop blood without damage
to blood vessels, by avoiding clams or elastic loops. LeGoo is the
solution form drug, when it is injected into blood vessels it forms gel
plug and stop the bleeding for 10-15 minutes. Floseal is also
antibleeding product is also used in surgical procedures to stop the
extra blood flow, manufactured by Baxter Healthcare Corporation.
The market of antibleeding gel is segmented as by product type, by Indication, by distribution channel and by geography. By product type the gel is further segmented as veterinary use and for human use. By indication, the market is further segmented as Biopsies of soft tissue, Trauma, Enucleations, Orthopedic surgeries, Mass removals, Dental extractions etc. The increasing incidences of road accidents, traumas will drive the market for antibleeding gel market. In accidental injuries amount of blood flows out and that may be cause death of person. The use of antibleeding gel in such cases may save the life of person.
In gel is also used in different type of
surgical process to control the blood flow. The gel can be also used by
athletes to immediate stop the bleeding by injury. The rising interest
among sports may also drive the market of anti-bleeding gel globally.
The gel can be also used for militants for instant healing and stop
bleeding by different type of injuries. By distribution channel the
market has been further segmented as retail Pharmacy, veterinary
pharmacy, drugstore, online pharmacy etc.
Geographically, the global antibleeding
gel market has been segmented into North America, Europe, Asia-Pacific,
Latin America and Middle East & Africa. North America and Europe
commanded a large share of the antibleeding gel market, As VETIGEL is
available in U.S. and U.K. veterinary markets and is anticipated to
transform standards. The product knowledge is more in these region will
also drive the antibleeding gel market. However, Asia-Pacific is
anticipated to witness the maximum growth rate during the forecast
period. Growth in the Asia-Pacific market is due to improvements in
healthcare infrastructure. The Latin America & Middle East will make
small contribution for the market for antibleeding gel.
Major players in Antibleeding gel market
include Cresilon, Inc., Baxter Healthcare Corporation, Z-Medica etc.
Cresilon, Inc. governs the major shares of Antibleeding gel as the
product provided by the only company for antibleeding.
No comments:
Post a Comment